Literature DB >> 21528045

Rifaximin for treatment of irritable bowel syndrome.

Douglas A Drossman1.   

Abstract

Entities:  

Year:  2011        PMID： 21528045      PMCID： PMC3079148     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Antibiotic therapy for the irritable bowel syndrome.

Authors:  Jan Tack
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

2.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

Review 3.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

4.  Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.

Authors:  Janet Yang; Hyo-Rang Lee; Kimberly Low; Soumya Chatterjee; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2007-05-23       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.